微RNA在慢性淋巴细胞白血病中的作用
Francesco Autore1, Alice Ramassone2, Luca Stirparo1
1Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.
International journal of molecular sciences
|August 12, 2023
概括
微RNAs (miRNAs) 在慢性淋巴细胞白血病 (CLL) 中发挥着至关重要的作用,通过作为瘤基因或瘤抑制剂. 了解miRNA功能为CLL治疗中新的治疗策略提供了潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 慢性淋巴细胞白血病 (CLL) 是一种流行成人白血病,具有不同的临床结果.
- 了解分子通路的进步推动了像BCR和BCL-2抑制剂这样的向疗法.
- 微RNAs (miRNAs) 是关键的基因表达调节剂,在CLL中具有新兴意义.
研究的目的:
- 审查特定miRNAs在CLL病理生理学中的作用.
- 探索miRNAs作为CLL治疗剂的潜力.
- 讨论基于miRNA的CLL疗法的当前局限性和未来方向.
主要方法:
- 文献综述侧重于CLL中的miRNA放松调节.
- 分析研究研究miRNA作为瘤基因和瘤抑制剂的功能.
- 对基于miRNA的治疗策略在CLL的研究的评估.
主要成果:
- 特定的miRNAs涉及到CLL预后,疾病进展和耐药性.
- 在CLL中,MiRNAs可以作为瘤基因和瘤抑制剂发挥作用.
- 新出现的证据表明miRNA疗效,单独或组合,用于CLL治疗.
结论:
- 毫米RNAs代表了新型CLL治疗开发的一个有希望的领域.
- 在CLL中miRNAs的临床应用目前受到安全性和生物特征的担忧的限制.
- 需要进一步的研究来克服挑战,并实现miRNAs在CLL中的全部治疗潜力.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K